The immunomodulatory potential of chickpea protein hydrolysate via ROS and NO pathways

Noelia M Rodríguez-Martín1, José Carlos Márquez-López1, José Antonio González-Jurado2

  • 1Instituto de la Grasa-CSIC, Plant Protein Group, Seville 41013, Spain.

Insights

Chickpea protein hydrolysate shows potential in managing inflammation by modulating reactive oxygen and nitrogen species. This bioactive compound may offer therapeutic benefits for human health.

Area of Science:

  • Nutritional Science
  • Immunology
  • Biochemistry

Background:

  • Reactive Oxygen Species (ROS) and Reactive Nitrogen Species (RNS) are crucial for immune signaling but uncontrolled production contributes to chronic inflammation.
  • Bioactive compounds, including protein hydrolysates, are investigated for their immunomodulatory and antioxidant properties.

Purpose of the Study:

  • To evaluate the potential of chickpea protein hydrolysate in modulating ROS/RNS stress and inflammation.
  • To assess its effects on endogenous antioxidant enzyme activities and pro-inflammatory markers in a cellular model of low-grade chronic inflammation.

Main Methods:

  • Utilized molecular biology techniques to measure Reactive Oxygen Species (ROS) and nitric oxide (NO) production.
  • Assessed cell metabolism and the impact of chickpea protein hydrolysate on key inflammatory pathways, including NF-κB and NLRP3 inflammasome.

Main Results:

  • Chickpea protein hydrolysate exposure dose-dependently increased ROS and NO release.
  • Demonstrated significant anti-inflammatory effects by inhibiting NF-κB and NLRP3 inflammasome components.

Conclusions:

  • Chickpea protein hydrolysates exhibit promising functional bioactive properties for therapeutic applications.
  • These hydrolysates can modulate oxidative stress and inflammatory responses, supporting human health and well-being.